A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria.
Mol Genet Metab Rep
; 33: 100939, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36406817
ALAS2, 5-aminolevulinate synthase 2; Clinical trial; DSMB, Data and Safety Monitoring Board; EPP, erythropoietic protoporphyria; Erythropoietic protoporphyria; FECH, ferrochelatase; IRE, iron-responsive element; IRP, IRE binding proteins; Iron; Photosensitivity; QoL, Quality of Life; X-linked protoporphyria; XLP, X linked protoporphyria; ePPIX, erythrocyte protoporphyrin
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Aspects:
Patient_preference
Language:
En
Journal:
Mol Genet Metab Rep
Year:
2022
Document type:
Article